Click Therapeutics to Participate in Cowen's 6th Annual FutureHealth Conference
Click Therapeutics, Inc. ("Click"), a leader in Digital Therapeuticstm solutions as medical treatments, today announced that David Benshoof Klein, founder and CEO, will participate in the Commercialization of Digital Therapeutics panel discussion at the Cowen 6th Annual FutureHealth Conference on Thursday, June 17, 2021 at 1:40pm ET.
About Click Therapeutics
Click Therapeutics, Inc. develops and commercializes software as medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click's Digital Therapeuticstm enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click's industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click is progressing a broad pipeline of Digital Therapeuticstm across a variety of high-burden therapeutic areas, including Major Depressive Disorder (MDD), Schizophrenia, Acute Coronary Syndrome (ACS), Chronic Pain, Migraine, Insomnia, COPD, Obesity, and more. For more information, visit ClickTherapeutics.com.
News published on and distributed by:
